IBB is ready to revisit the highs of 133 made in July 2015, after a 4x increase since 2011 which was the equivalent of the dot-com bubble.
Assuming that pandemic issues are going to be a recurring catalyst, biotech could be ready to take again the mantle of market leader from technology (maybe it is a relay?).
Anyway, it seems a cup-and-handle breakout from 130s is ready to go (supported by increased volume, and the fact the ATR is back to its highs).
Assuming that pandemic issues are going to be a recurring catalyst, biotech could be ready to take again the mantle of market leader from technology (maybe it is a relay?).
Anyway, it seems a cup-and-handle breakout from 130s is ready to go (supported by increased volume, and the fact the ATR is back to its highs).
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.